evolocumab • Recombinant human antibody to Human PCSK9. Evolocumab (also known as compound number AMG-145 or AMG145) is a monoclonal antibody designed for the treatment of hyperlipidemia. Evolocumab is a fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9).
Search
Read the Text Version
- 1 - 1
Pages: